GT200500219A - 4-(2,4-dicloro-5-metoxifenil)amino-6-metoxi-7([5-amino-sustituido)metil]-3-furil)-3-quinolincarbonitrilos comoinhibidores de quinasa. - Google Patents

4-(2,4-dicloro-5-metoxifenil)amino-6-metoxi-7([5-amino-sustituido)metil]-3-furil)-3-quinolincarbonitrilos comoinhibidores de quinasa.

Info

Publication number
GT200500219A
GT200500219A GT200500219A GT200500219A GT200500219A GT 200500219 A GT200500219 A GT 200500219A GT 200500219 A GT200500219 A GT 200500219A GT 200500219 A GT200500219 A GT 200500219A GT 200500219 A GT200500219 A GT 200500219A
Authority
GT
Guatemala
Prior art keywords
amino
quinolincarbonitrilos
metoxifenil
metoxi
dicloro
Prior art date
Application number
GT200500219A
Other languages
English (en)
Inventor
Diane Harris Boschelli
Asaf Alimardanov
Biqi Wu
Jay Thomas Afragola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500219A publication Critical patent/GT200500219A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCIÓN SE RELACIONA CON COMPUESTOS QUE TIENEN LA ESTRUCTURA DE FÓRMULA I, QUE INHIBEN LA ACTIVIDAD DE LAS QUINASAS, DICHO COMPUESTOS SON ÚTILES PARA EL TRATAMIENTO DEL CANCER.
GT200500219A 2004-08-16 2005-08-12 4-(2,4-dicloro-5-metoxifenil)amino-6-metoxi-7([5-amino-sustituido)metil]-3-furil)-3-quinolincarbonitrilos comoinhibidores de quinasa. GT200500219A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60182504P 2004-08-16 2004-08-16

Publications (1)

Publication Number Publication Date
GT200500219A true GT200500219A (es) 2006-03-07

Family

ID=35395715

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500219A GT200500219A (es) 2004-08-16 2005-08-12 4-(2,4-dicloro-5-metoxifenil)amino-6-metoxi-7([5-amino-sustituido)metil]-3-furil)-3-quinolincarbonitrilos comoinhibidores de quinasa.

Country Status (6)

Country Link
US (1) US7479561B2 (es)
AR (1) AR053409A1 (es)
GT (1) GT200500219A (es)
PE (1) PE20060495A1 (es)
TW (1) TW200612944A (es)
WO (1) WO2006023395A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200829555A (en) * 2006-11-10 2008-07-16 Astrazeneca Ab Chemical compounds
US20080119463A1 (en) * 2006-11-16 2008-05-22 Wyeth 4-Anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (AML)
WO2008064004A2 (en) * 2006-11-16 2008-05-29 Wyeth 4-anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (aml)
MX367055B (es) 2012-06-26 2019-08-02 Del Mar Pharmaceuticals El uso de una composición que comprende dianhidrogalactitol, diacetildianhidrogalactitol, y dibromodulcitol, y análogos o derivados de cada uno para el tratamiento de malignidades resistentes a inhibidores de tirosina cinasa.
CN103848785B (zh) * 2012-12-04 2016-07-13 上海医药集团股份有限公司 一类氘代3-氰基喹啉类化合物、其药用组合物、制备方法及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035851A1 (es) * 2000-03-28 2004-07-21 Wyeth Corp 3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6961765B2 (en) * 2000-04-06 2005-11-01 Bbx Technologies, Inc. System and method for real time monitoring and control of networked computers
RU2345069C2 (ru) 2003-08-19 2009-01-27 Уайт Холдингз Корпорейшн Способ получения 4-амино-3-хинолинкарбонитрилов

Also Published As

Publication number Publication date
US20060035930A1 (en) 2006-02-16
PE20060495A1 (es) 2006-07-14
AR053409A1 (es) 2007-05-09
US7479561B2 (en) 2009-01-20
WO2006023395A2 (en) 2006-03-02
WO2006023395A3 (en) 2006-06-08
TW200612944A (en) 2006-05-01

Similar Documents

Publication Publication Date Title
CL2020002146A1 (es) Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer.
NO20065148L (no) Monocykliske heterocykler som kinase inhibitorer
EA200901488A1 (ru) Замещенные имидазолопиридазины, как ингибиторы липидкиназы
SMT201300109B (it) Imidazopiridazincarbonitrili utili come inibitori di chinasi
UY27234A1 (es) Inhibidores novedosos de tirosina cinasa
CU23784B7 (es) Bencimidazoles sustituidos como inhibidores de cinasa
ECSP066717A (es) Compuestos de quinolina sustituidos
HRP20050533A2 (en) Aminoindazole derivatives and use thereof as kinase inhibitors
NO20081454L (no) Met-kinaseinhibitorer
EA201100447A1 (ru) Органические соединения
ECSP109953A (es) Derivados de piridazinona
UY29458A1 (es) Heterociclos sustituidos y usos de los mismos
EA201190158A1 (ru) Производные бензофуранила для применения в качестве ингибиторов глюкокиназы
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
ECSP055640A (es) Composiciones de pirazol útiles como inhibidores de gsk-3
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
ECSP088536A (es) DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR
SV2008003045A (es) Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes
MA32508B1 (fr) Composes organiques
DE602004013563D1 (de) Rantagonisten
EA200600689A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов raf киназы
EA200802050A1 (ru) Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp